Moxibustion for Nocturia
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40+
SponsorBuddhist Tzu Chi General Hospital
About this trial
Nocturia, the interruption of sleep due to nighttime voiding, severely compromises quality of life, emotional health, and overall well-being when occurring twice or more per night. Given that some patients experience inadequate responses to conventional Western therapies or harbor concerns about the long-term side effects of pharmaceuticals, many are turning to Traditional Chinese Medicine (TCM) for alternative solutions. This study utilized a randomized clinical trial design to investigate the efficacy and safety of acupoint moxibustion for nocturia.
Eligibility criteria
Qualifiers
Patients aged 40 years or older.
Experiencing two or more nocturia episodes per night.
Disqualifiers
Active urinary tract infection (UTI).
Poorly controlled diabetes mellitus (defined as HbA1c > 6.5%).
Presence of a neurogenic bladder caused by conditions such as multiple sclerosis, Parkinson's disease, stroke, spinal cord injury, or nerve damage resulting from major pelvic surgery.
Severe congestive heart failure (New York Heart Association [NYHA] functional class > II).
Trial design
Treatments tested in this trial
- Moxibustion
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov